e-learning
resources
Berlin 2008
Monday, 06.10.2008
Rehabilitation and influencing factors
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Physical activity and quality of life in subjects with chronic diseases; COPD compared to rheumatoid arthritis and diabetes
M. Arne, C. Janson, S. Janson, G. Boman, M. Emtner (Karlstad, Uppsala, Sweden)
Source:
Annual Congress 2008 - Rehabilitation and influencing factors
Session:
Rehabilitation and influencing factors
Session type:
Oral Presentation
Number:
2740
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Arne, C. Janson, S. Janson, G. Boman, M. Emtner (Karlstad, Uppsala, Sweden). Physical activity and quality of life in subjects with chronic diseases; COPD compared to rheumatoid arthritis and diabetes. Eur Respir J 2008; 32: Suppl. 52, 2740
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Effect of respiratory pathology on the quality of life for patients, suffering from rheumatoid arthritis
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012
Are smoking and COPD associated with ILD onset in rheumatoid arthritis?
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Factors associated with low-level physical activity in elderly patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015
Risk of obstructive sleep apnea in patients with rheumatoid arthritis and its impact on quality of life
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019
Nutritional status and health-related quality of life in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 484s
Year: 2001
Physical activity and risk of comorbidities in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Novel approaches for pulmonary rehabilitation in chronic lung diseases
Year: 2016
Nutritional status and health-related quality of life (HRQL) in patients admitted to hospital with acute exacerbation of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 235s
Year: 2002
The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases
Source: International Congress 2014 – Markers
Year: 2014
An exploration of pain experiences and their meaning in people with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Postural balance, respiratory muscles, and comorbidities in chronic respiratory disease
Year: 2016
A pilot study to assess the efficacy of breathlessness plans for patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
The frequency of the respiratory comorbidities in patients (pts) with rheumatoid arthritis (RA)
Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Year: 2021
Is anxiety and depression a barrier to enrolment in a study in chronic obstructive pulmonary disease (COPD)?
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016
Quality of life (QL) depending on psychological disorders (PD) of patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Comorbidities
Year: 2014
Quality of life of smokers depending on age, smoking history and COPD symptoms
Source: Annual Congress 2007 - Smoking and COPD
Year: 2007
Impact on patients' health status following early identification of a COPD exacerbation
Source: Eur Respir J 2007; 30: 907-913
Year: 2007
Relationship between dyspnea levels and health-related quality of life (HRQoL) in patients with stable chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 240s
Year: 2003
Risk factors of interstitial lung diseases in patients with rheumatoid arthritis.
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Prevalence and characteristics of anxiety and depression in patients with advanced COPD
Source: International Congress 2015 – Best abstracts in chronic care
Year: 2015
Assessment of quality of life of bronchiectasis patients associated with asthma and COPD.
Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases
Year: 2019
The lung in rheumatoid arthritis: drugs versus underlying disease
Source: Annual Congress 2009 - Lung disease in rheumatoid arthritis treated with tumour necrosis factor inhibitors: a pulmonary perspective
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept